Lincoln Stein

$383,286.80asActing Scientific Director and Head, Adaptive Oncology

Employed by Ontario Institute For Cancer Research in 2025, according to Government of Ontario public salary records.

Position

Acting Scientific Director and Head, Adaptive Oncology

Employer

Ontario Institute For Cancer Research

Salary Information

Historical salary and taxable benefits from 2008 to 2025.

YearPositionSalaryBenefitsPerformance
2025
Acting Scientific Director and Head, Adaptive Oncology
$383,286.80
$800.28
2024
Head, Adaptive Oncology
$383,286.80
$1,477.44
2.22%
2023
Head, Adaptive Oncology
$374,954.80
$1,462.86
2.07%
2022
Head, Adaptive Oncology
$367,348.80
$1,375.38
2021
Head, Adaptive Oncology
$367,348.80
$1,244.16
2020
Director and Senior Scientist
$367,348.80
$1,237.68
0.61%
2019
Director and Senior Scientist
$365,128.56
$1,218.24
0.36%
2018
Director and Senior Scientist
$363,807.35
$1,218.24
5.37%
2017
Head, Adaptive Oncology
$384,438.85
$1,218.24
1.04%
2016
Interim Scientific Director / Program Director and Senior Principal Investigator
$388,484.78
$1,218.24
55.31%
2011
Director & Senior Scientist
$250,129.92
$1,010.88
7.12%
2010
Director & Senior Scientist
$233,507.21
$1,093.50
1%
2009
Director/Senior Scientist
$231,194.31
$874.80
49.3%
2008
Director/Senior Scientist
$154,848.95
$38.88

Lincoln Stein, Acting Scientific Director and Head, Adaptive Oncology at Ontario Institute For Cancer Research, earned a disclosed salary of $383,286.80 in 2025 on the Ontario Sunshine List. Lincoln Stein has appeared on the Ontario Sunshine List 14 times between 2008 and 2025, with reported earnings peaking at $388,484.78 in 2016. In addition to salary, $800.28 in taxable benefits was disclosed for 2025. Ontario Institute For Cancer Research reports under the Other Public Sector Employers sector of Ontario's public sector salary disclosure.

Top earning Acting Scientific Director and Head, Adaptive Oncologys in Ontario Institute For Cancer Research

NameSalary
Lincoln Stein$383,286.80
NameSalary
Leslie Radvanyi
President and Scientific Director
$539,745.00
Christine Williams
Acting President and Head, Implementation Science
$395,996.12
Jared T. Simpson
Interim Scientific Director and Principal Investigator
$331,897.15
David E. Uehling
Interim Scientific Director, Therapeutic Innovation and Drug Discovery
$329,520.45
Peter Goodhand
Executive Lead
$321,484.80
Jeanette Dias D'Souza
Senior Vice President, Group Chief Financial Officer
$319,995.00
Robert V. Campos
Senior Director
$256,531.19